Meeting report: International workshop on implementation of biowaivers based on the biopharmaceutics classification system (BCS)
Even though the pivotal article stating the theoretical basis for a biopharmaceutics drug classification (1) was published almost 20 years ago, the extension of BCS-based biowaiver decisions to drugs belonging to BCS classes other than those showing high solubility and high permeability has not yet...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | Articulo |
Lenguaje: | Inglés |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/86668 |
Aporte de: |
id |
I19-R120-10915-86668 |
---|---|
record_format |
dspace |
institution |
Universidad Nacional de La Plata |
institution_str |
I-19 |
repository_str |
R-120 |
collection |
SEDICI (UNLP) |
language |
Inglés |
topic |
Farmacia BCS-based biowaiver Generic drug |
spellingShingle |
Farmacia BCS-based biowaiver Generic drug Cristofoletti, Rodrigo Shah, Vinod P. Langguth, Peter Polli, James E. Mehta, Mehul Abrahamsson, Bertil Dressman, Jennifer B. Quiroga, Pablo Meeting report: International workshop on implementation of biowaivers based on the biopharmaceutics classification system (BCS) |
topic_facet |
Farmacia BCS-based biowaiver Generic drug |
description |
Even though the pivotal article stating the theoretical basis for a biopharmaceutics drug classification (1) was published almost 20 years ago, the extension of BCS-based biowaiver decisions to drugs belonging to BCS classes other than those showing high solubility and high permeability has not yet reached a consensus among regulators, industrial scientists, and academics. Also, within some jurisdictions, BCS principles have not yet been incorporated into legal frameworks and thus have not been used to allow science- and risk-based regulatory flexibility.
This report provides a brief description of the presentations from the International Workshop on Implementation of Biowaivers based on the BCS in Buenos Aires, Argentina, that took place on March 5–6, 2015.
The meeting was cosponsored by National University of La Plata, Confederación Farmacéutica Argentina, International Pharmaceutical Federation (FIP), and the American Association of Pharmaceutical Scientists (AAPS).
The main objectives of the meeting were to describe the state of the art with respect to in vitro and in silico tools to support waiving in vivo bioequivalence studies and to foster discussion about implementing BCS-based biowaiver decisions to support generic drug registration in South America. Two hundred and fifteen scientists from universities, the pharmaceutical industry, and regulatory authorities took part in this meeting |
format |
Articulo Articulo |
author |
Cristofoletti, Rodrigo Shah, Vinod P. Langguth, Peter Polli, James E. Mehta, Mehul Abrahamsson, Bertil Dressman, Jennifer B. Quiroga, Pablo |
author_facet |
Cristofoletti, Rodrigo Shah, Vinod P. Langguth, Peter Polli, James E. Mehta, Mehul Abrahamsson, Bertil Dressman, Jennifer B. Quiroga, Pablo |
author_sort |
Cristofoletti, Rodrigo |
title |
Meeting report: International workshop on implementation of biowaivers based on the biopharmaceutics classification system (BCS) |
title_short |
Meeting report: International workshop on implementation of biowaivers based on the biopharmaceutics classification system (BCS) |
title_full |
Meeting report: International workshop on implementation of biowaivers based on the biopharmaceutics classification system (BCS) |
title_fullStr |
Meeting report: International workshop on implementation of biowaivers based on the biopharmaceutics classification system (BCS) |
title_full_unstemmed |
Meeting report: International workshop on implementation of biowaivers based on the biopharmaceutics classification system (BCS) |
title_sort |
meeting report: international workshop on implementation of biowaivers based on the biopharmaceutics classification system (bcs) |
publishDate |
2015 |
url |
http://sedici.unlp.edu.ar/handle/10915/86668 |
work_keys_str_mv |
AT cristofolettirodrigo meetingreportinternationalworkshoponimplementationofbiowaiversbasedonthebiopharmaceuticsclassificationsystembcs AT shahvinodp meetingreportinternationalworkshoponimplementationofbiowaiversbasedonthebiopharmaceuticsclassificationsystembcs AT langguthpeter meetingreportinternationalworkshoponimplementationofbiowaiversbasedonthebiopharmaceuticsclassificationsystembcs AT pollijamese meetingreportinternationalworkshoponimplementationofbiowaiversbasedonthebiopharmaceuticsclassificationsystembcs AT mehtamehul meetingreportinternationalworkshoponimplementationofbiowaiversbasedonthebiopharmaceuticsclassificationsystembcs AT abrahamssonbertil meetingreportinternationalworkshoponimplementationofbiowaiversbasedonthebiopharmaceuticsclassificationsystembcs AT dressmanjenniferb meetingreportinternationalworkshoponimplementationofbiowaiversbasedonthebiopharmaceuticsclassificationsystembcs AT quirogapablo meetingreportinternationalworkshoponimplementationofbiowaiversbasedonthebiopharmaceuticsclassificationsystembcs |
bdutipo_str |
Repositorios |
_version_ |
1764820489172156422 |